Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
INMD Stock Forecast 2026-2027
$14.04
Current Price
$952.20M
Market Cap
Buy 1
Hold 6
Sell 0
Wall St Analyst Ratings
Distance to INMD Price Targets
+49.6%
To High Target of $21.00
+14.0%
To Median Target of $16.00
+6.8%
To Low Target of $15.00
INMD Price Momentum
-1.5%
1 Week Change
-2.0%
1 Month Change
-15.1%
1 Year Change
-4.4%
Year-to-Date Change
-29.0%
From 52W High of $19.78
+6.8%
From 52W Low of $13.14
📊 TOP ANALYST CALLS
Did INMD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Inmode is one of their latest high-conviction picks.
Latest INMD Stock Price Targets & Analyst Predictions
Based on our analysis of 11 Wall Street analysts, INMD has a neutral consensus with a median price target of $16.00 (ranging from $15.00 to $21.00). The overall analyst rating is Buy (6.3/10). Currently trading at $14.04, the median forecast implies a 14.0% upside. This outlook is supported by 1 Buy, 6 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Matt Miksic at Barclays, projecting a 49.6% upside. Conversely, the most conservative target is provided by Caitlin Cronin at Canaccord Genuity, suggesting a 6.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
INMD Analyst Ratings
1
Buy
6
Hold
0
Sell
INMD Price Target Range
Low
$15.00
Average
$16.00
High
$21.00
Current: $14.04
Latest INMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for INMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 17, 2025 | Canaccord Genuity | Caitlin Cronin | Hold | Maintains | $15.00 |
| Nov 6, 2025 | UBS | Danielle Antalffy | Neutral | Maintains | $16.00 |
| Oct 10, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Oct 10, 2025 | Canaccord Genuity | Caitlin Cronin | Hold | Maintains | $16.00 |
| Jul 30, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Jul 30, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $21.00 |
| Jul 11, 2025 | Canaccord Genuity | Caitlin Cronin | Hold | Maintains | $15.00 |
| Apr 30, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $24.00 |
| Apr 29, 2025 | BTIG | Sam Eiber | Neutral | Downgrade | $N/A |
| Apr 29, 2025 | Canaccord Genuity | Caitlin Cronin | Hold | Maintains | $15.00 |
| Apr 29, 2025 | UBS | Danielle Antalffy | Neutral | Maintains | $16.25 |
| Apr 28, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Apr 14, 2025 | Jefferies | Matthew Taylor | Hold | Maintains | $15.00 |
| Apr 14, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Apr 9, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Feb 5, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $29.00 |
| Feb 4, 2025 | Needham | Mike Matson | Hold | Maintains | $N/A |
| Jan 9, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $26.00 |
| Oct 31, 2024 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Oct 21, 2024 | Alliance Global Partners | Buy | Initiates | $N/A |
InMode Ltd. (INMD) Competitors
The following stocks are similar to Inmode based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
InMode Ltd. (INMD) Financial Data
InMode Ltd. has a market capitalization of $952.20M with a P/E ratio of 6.7x. The company generates $364.49M in trailing twelve-month revenue with a 41.0% profit margin.
Revenue growth is -28.5% quarter-over-quarter, while maintaining an operating margin of +22.4% and return on equity of +21.5%.
Valuation Metrics
Market Cap
$952.20M
Enterprise Value
$390.37M
P/E Ratio
6.7x
PEG Ratio
-0.1x
Price/Sales
2.6x
Growth & Margins
Revenue Growth (YoY)
-28.5%
Gross Margin
+77.6%
Operating Margin
+22.4%
Net Margin
+41.0%
EPS Growth
-57.1%
Financial Health
Cash/Price Ratio
+59.9%
Current Ratio
9.8x
Debt/Equity
0.9x
ROE
+21.5%
ROA
+7.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
InMode Ltd. (INMD) Business Model
About InMode Ltd.
What They Do
Provides innovative medical technologies for aesthetics.
Business Model
InMode Ltd. designs and manufactures minimally invasive aesthetic healthcare solutions, generating revenue through the sale of advanced medical devices that utilize radiofrequency, light, and laser technologies. Their products are used in various aesthetic procedures, which are increasingly popular due to their effectiveness and minimal recovery time.
Additional Information
Founded in Israel, InMode has expanded globally, serving clinics and practitioners across multiple regions. The company's focus on innovation positions it as a key player in the rapidly growing aesthetic medical device industry, catering to the rising demand for non-invasive treatments in cosmetic surgery, dermatology, and women's health.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
599
CEO
Mr. Moshe Mizrahy
Country
Israel
IPO Year
2019
Website
www.inmodemd.comInMode Ltd. (INMD) Latest News & Analysis
Latest News
Quick Summary
InMode Ltd. will hold a conference call on February 10, 2026, at 8:30 a.m. Eastern Time, as announced on January 8, 2026.
Why It Matters
The upcoming conference call could provide insights into InMode Ltd.'s financial performance and strategic direction, impacting stock valuation and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
InMode Ltd. trades at a discount, with net cash covering 58% of market cap. Despite an 85% drawdown since 2021, strong fundamentals support a buy rating amid operational challenges.
Why It Matters
InMode Ltd.'s strong balance sheet and cash position suggest stability, while aggressive buybacks and improving fundamentals may lead to significant upside, making it an attractive opportunity for investors.
Source: Seeking Alpha
Market Sentiment:
Positive
InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript
2 months ago
Quick Summary
InMode Ltd. (INMD) will discuss its Q3 2025 earnings on November 5, 2025, at 8:30 AM EST, featuring CEO Moshe Mizrahy and CFO Yair Malca.
Why It Matters
InMode's Q3 2025 earnings call indicates upcoming financial performance insights, impacting stock valuation and investor sentiment based on company progress and market responses.
Source: Seeking Alpha
Market Sentiment:
Neutral
InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins
2 months ago
Quick Summary
InMode Ltd. (NASDAQ: INMD) has released its consolidated financial results for Q3 2025, ending September 30. Further details on performance were not specified.
Why It Matters
InMode's Q3 financial results can indicate company performance, impacting stock valuation, investor sentiment, and potential growth prospects in the medical technology sector.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
InMode Ltd. announced news from Irvine, California, on November 3, 2025. Further details were not provided in the excerpt.
Why It Matters
InMode Ltd.'s news may signal developments in their business operations or financial performance, impacting stock valuation and investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
InMode Ltd. (Nasdaq: INMD) will participate in two investor conferences in November: UBS Global Healthcare Conference on Nov. 10 in Florida and Jefferies Global Healthcare Conference on Nov. 18 in London.
Why It Matters
InMode's participation in key investor conferences highlights its engagement with the investment community, potentially impacting stock visibility, credibility, and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About INMD Stock
What is InMode Ltd.'s (INMD) stock forecast for 2026?
Based on our analysis of 11 Wall Street analysts, InMode Ltd. (INMD) has a median price target of $16.00. The highest price target is $21.00 and the lowest is $15.00.
Is INMD stock a good investment in 2026?
According to current analyst ratings, INMD has 1 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $14.04. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for INMD stock?
Wall Street analysts predict INMD stock could reach $16.00 in the next 12 months. This represents a 14.0% increase from the current price of $14.04. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is InMode Ltd.'s business model?
InMode Ltd. designs and manufactures minimally invasive aesthetic healthcare solutions, generating revenue through the sale of advanced medical devices that utilize radiofrequency, light, and laser technologies. Their products are used in various aesthetic procedures, which are increasingly popular due to their effectiveness and minimal recovery time.
What is the highest forecasted price for INMD InMode Ltd.?
The highest price target for INMD is $21.00 from Matt Miksic at Barclays, which represents a 49.6% increase from the current price of $14.04.
What is the lowest forecasted price for INMD InMode Ltd.?
The lowest price target for INMD is $15.00 from Caitlin Cronin at Canaccord Genuity, which represents a 6.8% increase from the current price of $14.04.
What is the overall INMD consensus from analysts for InMode Ltd.?
The overall analyst consensus for INMD is neutral. Out of 11 Wall Street analysts, 1 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $16.00.
How accurate are INMD stock price projections?
Stock price projections, including those for InMode Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 15, 2026 3:14 AM UTC